SEC Form 4 · accession 0000899243-16-025734
PALVELLA THERAPEUTICS, INC. · PVLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julian Adams
Director
Period of report
Jul 25, 2016
Accepted (ET)
Jul 26, 2016 · 7:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583648
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.73 | Jul 25, 2016 | A | 30,000 | A | — | Jul 25, 2026 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1The stock option will vest in four equal quarterly installments beginning from the date of grant and ending in twelve months, subject to the Reporting Person's continued service as a director.